In this Global Health Magazine opinion piece, Aaron Emmel, senior policy advisor at PATH, examines a momentum for reform in foreign aid that “has been mounting in both Congress and the Administration,” writing, “Now we face one of the most austere budget environments in our nation’s history, making the need for an efficient, accountable, transparent, effective, and strategic foreign assistance policy all the more important. Clearly, foreign aid needs to be reformed so that it can do the job it was originally intended for: assisting the people who need it most in the most efficient and effective way possible.”
In this New York Times editorial, Carol Giacomo, journalist and member of the newspaper’s editorial board, reports on a decline in U.S. foreign aid, writing, “There is a lot of public misunderstanding about foreign aid,” adding, “For the sake of national security, this country cannot afford to retreat from the world. Its investment in the State Department and foreign aid helps advance peace and stability by feeding starving people, providing access to doctors and medicines, opening new markets, promoting democracy, curbing nuclear arms and strengthening allies with military and economic assistance.”
In a letter to the Guardian in response to the news that the U.K. Department for International Development (DfID) plans to cut bilateral aid for HIV/AIDS by nearly one-third, Nathan Ford, medical coordinator for Medecins Sans Frontieres, writes that the agency’s decision “comes at a critical moment,” after “[v]arious studies published in the past year have shown widespread access to treatment and prevention can dramatically cut HIV/AIDS transmission, and allow for consideration of an end to the epidemic.”
Experts Take Study On Contraceptive Use, HIV Risk Seriously But Warn About Drawing Conclusions Prematurely Because Of Study's 'Methodological Weaknesses'
In this post in RH Reality Check, Jodi Jacobson, editor-in-chief of the blog, responds to an article published in the New York Times on Tuesday regarding a study suggesting that “HIV-negative women using injectable contraception might face a two-fold risk of acquiring HIV from their infected partners, and that HIV-positive women using…
In this Scientist opinion piece, Edward Partridge, president of the American Cancer Society and director of the Comprehensive Cancer Center at the University of Alabama at Birmingham, Elizabeth Mayer-Davis, president of health care and education at the American Diabetes Association, and Ralph Sacco, immediate past president of the American Heart Association/American Stroke Association and professor and chairman of neurology at the Miller School of Medicine at the University of Miami, write that while last month’s U.N. High-level Meeting to discuss non-communicable diseases (NCDs) helped to raise awareness about the burden of NCDs, several important steps must be taken immediately to prevent and control the diseases.
In this Huffington Post opinion piece, singer and actor Mandy Moore writes that during her travels as a PSI ambassador, “sometimes the disconnect I see is truly striking: people can get cold Coca Cola, but far too infrequently malaria drugs; most own mobile phones, but don’t have equal access to pre-natal care.” Noting that technology has helped the U.S. and Europe improve health standards and therefore strengthen their economies, she writes, “It’s simple and logical, but to grow economies, the basic building block of health is necessary.”
In this Guardian opinion piece, Jill Filipovic, a freelance writer and blogger at Feministe, reports on how Unitaid, an organization “largely funded through innovating financing methods, including a tax on airplane tickets,” is working to increase access to HIV/AIDS, malaria and tuberculosis treatments in developing countries through “patent pools” and urges pharmaceutical companies to “get on board.”
“It’s time to respond … [to Americans who] have not been given a comprehensive explanation of how U.S. investments in foreign aid — particularly global health — are used or how they benefit Americans here at home,” Karl Hofmann, president and CEO of PSI, writes in a Huffington Post opinion piece. “Global health investments benefit the globe. … Healthy families yield healthy societies and economies. Everyone everywhere benefits,” he states.
“For the Bill & Melinda Gates Foundation, the Global Fund [to Fight AIDS, Tuberculosis and Malaria] is an invaluable partner, and the progress they have achieved is bringing us closer than ever to the reality of global health equity,” Joe Cerrell, director of the Gates Foundation’s European office, writes in an AlertNet opinion piece, adding, “Every day, programs supported by the Global Fund save at least 4,400 lives.”
In this post in the Guardian’s “Sustainable Business Blog,” Mark Kramer, founder and managing director of the non-profit consulting firm FSG and senior fellow at the CSR Initiative at the Harvard Kennedy School of Government, examines how “[g]lobal corporations are increasingly finding ways to create shared value — pursuing business initiatives that improve social and environmental conditions while earning the company a profit and conferring a competitive advantage.”